City
Epaper

Shree Slimming contributing in this pandemic to reduce a major risk factor - Obesity, which is emerging as a novel risk

By ANI | Published: June 15, 2021 2:36 PM

Obesity is a huge healthcare concern because it is associated with several chronic diseases including type 2 diabetes, heart diseases, stroke and certain types of cancers.

Open in App

Obesity is a huge healthcare concern because it is associated with several chronic diseases including type 2 diabetes, heart diseases, stroke and certain types of cancers.

Obesity significantly reduces the quality of life and is one of the leading causes of death, worldwide.

Recent evidence has shown that obesity weakens the immune system and therefore, making the host vulnerable to infectious diseases. Indeed, Obesity has emerged as a strong risk factor for severe disease in the current pandemic disease, COVID-19.

Several independent studies have demonstrated that obese subjects with COVID-19 have a higher risk of severe disease, hospitalization, and increased probability of death.

The global pandemic of obesity and overweight now affects between 2.8 and 3.5 billion of the world population and shows no signs of abatement. Treatment for what is now recognized as a chronic disease includes pharmacotherapy, considered an essential component of a comprehensive therapy.

The pace of the US Food and Drug Administration approval for obesity drugs has been glacial. In the last 20 years, the US Food and Drug Administration has approved 208 drugs for cancer, 118 for cardiovascular diseases, 168 for neurological diseases, and 223 endocrinology drugs, but only 6 for obesity, 2 of which have been taken off-market.

Currently, there are only 9 drugs approved by the FDA for obesity treatment. Due to which off-label drug businesses have increased rapidly.

Be it weight loss or weight gain, an unhealthy body is something that leads to mental problems as well, and to combat such issues, is fighting obesity with new-age methods by a young health entrepreneur, who is contributing his best in this pandemic of Covid19 to help the society by reducing risk factors.

Dr. Pratayksha has practiced Obesity Medicine & Weight Management in India since 2007. His expertise in caring for patients with weight problems is well known both across India and internationally and also had been two times gold medalist for it.

He is widely regarded as an expert in his field because of his research and has published a scientific book on obesity treatment and the use of anti-obesity products. He has also given many lectures and presentations across the globe on anti-obesity. He is an acknowledged Research Member of many organizations including the Indian Obesity Network, Canadian Obesity Network, Indian Laser Association, and World's Obesity Organization.

Dr Pratayksha's Shree Skin Care & Slimming Centre, or Shree Slimming as it is popularly called, is committed to providing an exceptional quality of obesity management and medical care with an efficient, knowledgeable, and caring staff in a pleasant and relaxing environment. Shree Slimming team believes that Obesity Medicine Specialists have a moral obligation to their patients and society as a whole to analyze their results and to contribute to improvements in treatment.

Dr. Pratayksha devotes many hours weekly to staying current so he can provide the best care available. He plans effective care management for all patients, which prevents further comorbidities. Dr. Pratayksha is loved by his patients, who attest to an improvement in quality of life after the treatment.

He takes the time to listen to his patients, educates himself on all cutting-edge techniques and medical knowledge. He has introduced advanced skills with techniques as Non-Surgical Bariatric. Many of his patients have and continue to participate anonymously in research studies.

Whether you have a little or a lot to lose, Dr. Pratayksha and his foundation Shree Skin Care and Slimming Centre have the blueprint to help you quickly and safely achieve your weight loss and health goals.

This story is provided by PNN.will not be responsible in any way for the content of this article. (ANI/PNN)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: fdaUs Food And Drug Administration
Open in App

Related Stories

MaharashtraNashik: 1,944 kg of Contaminated Sweets Destroyed at Saptashrungi Gadh, Vani After FDA Crackdown

HealthDiffering guidelines from FDA and WHO spells adverse global impact

InternationalUS FDA okays 1st over-the-counter birth control pill

Other SportsPV Sindhu, Lakshya Sen move to quarter-finals of US Open badminton 

LifestyleStud reveals successful cooperation depends on good mindreading abilities

Business Realted Stories

BusinessIndia will be country of honour at Choose France Summit hosted by French President

BusinessCCI approves acquisition of additional shares in Sikkim Urja Limited by Greenko Energies Private Limited

BusinessGoogle launches Pixel 8a with industry-first AI features in India

BusinessProfit of IGL surged by 16% in Q4 FY24

BusinessEPFO evaluating course of action over HC ruling on foreign workers